Matthias Pfisterer, of University Hospital of Basel, Switzerland, and colleagues compared a N-terminal BNP – guided strategy to the standard symptom-guided therapy for 499 patients aged 60 years or older with congestive heart failure a a previous hospitalization for heart failure within 1 year and N-terminal BNP level of 2 or more times the upper limit of normal buy cialis online . The study had a 18 – month follow – up. Patients were to be a treatment a treatment to reduce the symptoms of a certain level of heart failure or treatment to reach BNP level of 2 times or less the upper limit of normal , and the symptoms of a certain level of heart failure .
Treatment of heart failure by BNP performed better results in patients aged 60 to 75 years but not in those 75 years or older. The results of the TIME – CHF study suggest that persistence in intensifying medical therapy seems to be the key to optimal clinical outcomes in patients aged 60 to 74 years, while it may not be beneficial push doses to the limits in patients aged 75 years or older, the authors write. Together with the main findings of the TIME – CHF study this study underlines the need for new studies to specifically to the large population of elderly. Failure . Continue reading